The stress response to trauma and surgery.
J P Desborough
https://pubmed.ncbi.nlm.nih.gov/10927999Actively Recruiting
Led by Peking University Shenzhen Hospital · Updated on 2025-12-18
112
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the use of the MGRNOX index, derived from electroencephalogram (EEG) signals, to guide opioid pain management during general anesthesia in patients undergoing laparoscopic cholecystectomy. The study aims to see if this method can reduce opioid consumption, specifically remifentanil, compared to standard clinical care. Pain control during surgery is important to avoid complications related to too much or too little opioid use, and no current monitoring device is considered the definitive standard for guiding analgesic dosing. The trial compares two groups: one where remifentanil dosing is adjusted to keep the MGRNOX index between 30 and 50 during surgery while also monitoring blood pressure and heart rate, and a control group where dosing adjustments are based on blood pressure and heart rate alone. Both groups receive anesthesia induction followed by intraoperative remifentanil administration with adjustments as needed. The study uses a randomized, triple-blind design to evaluate the effectiveness of this EEG-based monitoring device. Participants will be monitored throughout the surgery, with opioid consumption measured from anesthesia induction until the final wound closure. Additional assessments include pain scores one hour after extubation, incidences of unexpected events and complications, and use of sedative and vasoactive drugs during surgery. This comprehensive evaluation will help determine if the MGRNOX-guided approach can optimize opioid use and improve surgical outcomes. The study runs until May 2026 and is sponsored by Peking University Shenzhen Hospital.
CONDITIONS
Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of surgery until final wound closure
Participants undergo laparoscopic cholecystectomy under general anesthesia. They receive either MGRNOX index-guided analgesia or standard clinical care to manage opioid dosing during surgery.
1 visit (in-person, during surgery)
Duration - At least 1 hour after surgery
Participants are monitored for pain and complications during at least 1 hour in the post-anesthesia care unit (PACU) after surgery.
1 follow-up visit (in-person, post-surgery)
Total: 1 location
1
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China
Actively Recruiting
T
Tao Luo, MD,PHD
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J P Desborough
https://pubmed.ncbi.nlm.nih.gov/10927999Talmage D Egan
https://pubmed.ncbi.nlm.nih.gov/31104756D Fletcher, V Martinez
https://pubmed.ncbi.nlm.nih.gov/24829420Matthias Gruenewald, Christoph Ilies
https://pubmed.ncbi.nlm.nih.gov/24012235Esra Kutlu Yalcin, Jorge Araujo-Duran, Alparslan Turan
https://pubmed.ncbi.nlm.nih.gov/34842026I Bergmann, A Göhner, T A Crozier...
https://pubmed.ncbi.nlm.nih.gov/23220856Henry D Upton, Guy L Ludbrook, Andrew Wing...
https://pubmed.ncbi.nlm.nih.gov/28598927Yu Jiang, Jian-Ming Ding, Xi-Xi Hao...
https://pubmed.ncbi.nlm.nih.gov/37593599Fleur Meijer, Maarten Honing, Tessa Roor...
https://pubmed.ncbi.nlm.nih.gov/32950246Dandan Ma, Jiahui Ma, Huayong Chen...
https://pubmed.ncbi.nlm.nih.gov/36091708